Meet the Team

Ms. Kathryn Hayashi is the President and CEO of TRIUMF Innovations, the business interface and commercialization arm, connecting TRIUMF, Canada’s particle accelerator centre, to the private sector via industry partnerships, licensing, and company creation.  TRIUMF Innovations is the co-lead with CPDC for the Canadian Medical Isotope Ecosystem (CMIE at www.cmie.ca), a new Strategic Innovation Fund project that will provide support and funding for growing Canada’s medical isotope sector, including a new CMIE Development Fund providing matching funds for new medical isotope innovation projects.

Ms. Hayashi is a Chartered Professional Accountant with more than 25 years of operational and strategic planning, finance and governance experience in not-for-profit organizations, public and private companies, start-ups, and commercialization accelerators/incubators. 

Prior to TRIUMF Innovations, she was the Founding Chief Financial Officer of The Centre for Drug Research and Development (now adMare Bioinnovations), Canada’s national drug development and commercialization engine. In addition to her work establishing CDRD as a leader in pre-clinical translational research and commercialization, Ms. Hayashi presides as a Director and Audit Committee Chair for Michael Smith Health Research BC, Center for Commercialization and Cancer Immunotherapy at the Hôpital Maisonneuve-Rosemont, as well as Nimbus Synergies health tech fund and Discovery Parks technology incubator.

Andrew Thiele is the Executive Director of the Canadian Nuclear Isotope Council an independent not-for-profit organization convened specifically to advocate for our country’s role in the production of the world’s isotope supply. Andrew is a graduate of the Munk school of Global Affairs the University of Toronto and prior to becoming Executive Director Andrew spent 10 years at Bruce Power, the Ontario Chamber of Commerce, and within the Ontario Government.

Melody Greaves  In her current role as Manager of Business Strategy with the Canadian Nuclear Isotope Council, Melody Greaves has led the development of the organizations’ advocacy efforts through the Isotopes for Hope campaign, an ambitious vision to double Canada’s production of medical isotopes by 2030. Melody is a dedicated professional with experience working with not-for-profit organizations across various sectors and is committed to advancing public policy and facilitating industry-wide collaboration. Melody holds a Master of Applied Politics degree, focusing on public and environmental policy and a bachelor’s degree in Political Science and French.

Sangeeta Hussain  A graduate of TAFE, Sydney Australia, Sangeeta Hussain is a Senior Executive Assistant of TRIUMF Innovations with 10+ years of experience supporting C-suite executives.  A master of organization and efficiency, she thrives on challenges, coordinating high-stakes meetings and ensuring seamless operations.

Prior to joining TRIUMF Innovations, her career included Executive Assistant to Leader of Opposition at Parliament of Fiji, Embassy of the Republic of Korea, Office Manager at Sydney, Australia, BC Cancer Agency, Administrative Support during the initial implementation of Agency for Pathology of Medicine at PHSA and has executed successful BC healthcare providers conference for LifeLabs.

Mohamed graduated from McMaster University with a Master’s in Biomedical Discovery and Commercialization, and has a dedicated career working for nonprofit organizations. He currently serves at CPDC as Manager, Business Development, and plays a supporting role for the Canadian Medical Isotope Ecosystem (CMIE). Mohamed has a strong foundation in both the science and business aspects of the Biotech sector. In his role, he aims to drive growth and foster strategic partnerships to drive the goal of making nuclear medicine available for all Canadians